Interestingly, acting as TLR4 antagonists, naloxone and naltrexone inhibit the opioid- or LPS-induced TLR4 signaling pathway (9, 25) and reverse TLR4-related neuropathic pain (31, 32). The gene discussed is TLR4; the disease is neuropathic pain.